1. Home
  2. Labeler Index
  3. Altor Bioscience, Llc, An Indirect Wholly-owned Subsidiary Of Immunitybio, Inc.
  4. NDC Product Code: 81481-803 Anktiva

NDC 81481-803 Anktiva

Nogapendekin Alfa Inbakicept-pmln Solution Intravesical - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 81481-803?
  4. Anktiva Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Pharmacologic Classes

Product Information

Get all the details for National Drug Code (NDC) 81481-803 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
81481-803
Proprietary Name:
Anktiva
Non-Proprietary Name: [1]
Nogapendekin Alfa Inbakicept-pmln
Substance Name: [2]
Nogapendekin Alfa Inbakicept-pmln
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s): [4]
Intravesical - Administration within the bladder.
Labeler Name: [5]
Altor Bioscience, Llc, An Indirect Wholly-owned Subsidiary Of Immunitybio, Inc.
Labeler Code:
81481
Product Label ID:
eae31db8-3e7a-d9e0-708d-74419d1b50ff
FDA Application Number: [6]
BLA761336
Marketing Category: [8]
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date: [9]
05-06-2024
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N
Code Navigator:

Code Structure Chart

Product Details

What is NDC 81481-803?

The NDC code 81481-803 is assigned by the FDA to the product Anktiva which is a human prescription drug product labeled by Altor Bioscience, Llc, An Indirect Wholly-owned Subsidiary Of Immunitybio, Inc.. The generic name of Anktiva is nogapendekin alfa inbakicept-pmln. The product's dosage form is solution and is administered via intravesical form. The product is distributed in a single package with assigned NDC code 81481-803-01 1 vial, glass in 1 box / .4 ml in 1 vial, glass. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Anktiva?

ANKTIVA in combination with Bacillus Calmette-Guérin (BCG) is indicated for the treatment of adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.

What are Anktiva Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are Anktiva UNII Codes?

The UNII codes for the active ingredients in this product are:

  • NOGAPENDEKIN ALFA INBAKICEPT-PMLN (UNII: 7TK323DLA0)
  • NOGAPENDEKIN ALFA INBAKICEPT-PMLN (UNII: 7TK323DLA0) (Active Moiety)

Which are Anktiva Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Anktiva?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 2682684 - nogapendekin alfa inbakicept-pmln 400 MCG in 0.4 ML Injection
  • RxCUI: 2682684 - 0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Injection
  • RxCUI: 2682684 - nogapendekin alfa inbakicept-pmln 400 MCG per 0.4 ML Injection
  • RxCUI: 2682691 - Anktiva 400 MCG in 0.4 ML Injection
  • RxCUI: 2682691 - 0.4 ML nogapendekin alfa inbakicept-pmln 1 MG/ML Injection [Anktiva]

Which are the Pharmacologic Classes for Anktiva?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".